Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa

Antimicrob Agents Chemother. 2008 Mar;52(3):1173-5. doi: 10.1128/AAC.01212-07. Epub 2008 Jan 7.

Abstract

In a university hospital, time-series analysis revealed a significant relationship between antibiotic (aminoglycoside, fluoroquinolone, and cefepime) use and incidence of MexXY-OprM-overproducing Pseudomonas aeruginosa. In vitro experiments confirm that such mutants were readily selected from both PAO1 and clinical strains when grown in the presence of these antibiotics.

MeSH terms

  • Aminoglycosides / pharmacology
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Outer Membrane Proteins / genetics
  • Bacterial Outer Membrane Proteins / metabolism*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Cefepime
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use
  • Culture Media
  • Drug Resistance, Multiple / genetics*
  • Fluoroquinolones / pharmacology
  • Fluoroquinolones / therapeutic use
  • France
  • Hospitals, University
  • Humans
  • Incidence
  • Membrane Transport Proteins / genetics
  • Membrane Transport Proteins / metabolism*
  • Microbial Sensitivity Tests
  • Mutation
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification
  • Pseudomonas aeruginosa / metabolism

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Bacterial Proteins
  • Cephalosporins
  • Culture Media
  • Fluoroquinolones
  • Membrane Transport Proteins
  • MexXY protein, Pseudomonas aeruginosa
  • OprM protein, Pseudomonas aeruginosa
  • Cefepime